Strip Meniscometry in Dry Eye Evaluation

NCT06120894 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 21

Last updated 2023-11-07

No results posted yet for this study

Summary

Strip meniscometry is a relatively new method for evaluating the tear meniscus. The aim of the study is to evaluate the possible effect of cataract surgery on ocular surface disease and to assess the possible benefit of strip meniscometry in the preoperative and postoperative evaluation of patients.

Conditions

Interventions

DIAGNOSTIC_TEST

Central visual acuity

Measurement of central visual acuity using Snellen optotype chart.

DIAGNOSTIC_TEST

Intraocular pressure measurement

Measurement of intraocular pressure using non-contact Canon TX-20P tonometer.

DIAGNOSTIC_TEST

Slit lamp examination

Slit lamp examination of the anterior and posterior segment of the eye after pharmacological dilation of the pupil using application of short-time mydriatics (1% tropicamide and 10% phenylephrine).

DIAGNOSTIC_TEST

Refraction and keratometry

Measurement of refraction and keratometry using refractometer Nidek ARK-1a.

DIAGNOSTIC_TEST

Optical biometry

Measurement of optical biometry using biometer Argos (Barrett or SRK/T formula).

DIAGNOSTIC_TEST

Strip meniscometry (SM)

Strip meniscometry examination using strip meniscometry tube.

DIAGNOSTIC_TEST

Lid Parallel Conjunctival Folds test (LIPCOF)

Evaluation of lid parallel conjunctival folds using slit lamp examination.

DIAGNOSTIC_TEST

Staining of the ocular surface with fluorescein

Evaluation of ocular surface fluorescein staining using Oxford scheme.

DIAGNOSTIC_TEST

Tear break up time test (TBUT)

Evaluation of tear break up time using slit lamp examination.

OTHER

Ocular Surface Disease Index questionnaire (OSDI)

Evaluation of Ocular Surface Disease Index using Ocular Surface Disease Index questionnaire.

Sponsors & Collaborators

  • Palacky University

    collaborator OTHER
  • University Hospital Olomouc

    lead OTHER

Principal Investigators

  • Marta Karhanova, MD, PhD · University Hospital Olomouc and Palacky University Olomouc

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2021-11-01
Primary Completion
2022-09-30
Completion
2022-09-30

Countries

  • Czechia

Study Locations

More Related Trials

Entities

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06120894 on ClinicalTrials.gov